WHWK Award Disclosure
Lennon David James · SEC Form 4 · Filed Sep 15, 2026
Award
Calculated transaction value
$0
Lennon David James Chief Executive Officer
WHWK
Transaction date
Sep 15, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed same day
WHWK daily price context
Close on/before transaction
$4.09
Sep 15, 2026
Close before public filing
$4.07
Sep 14, 2026
Return since public filing
-0.74%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock option (right to buy) on Common Stock
- Quantity / price
- 193,957 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001995275-26-000016
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. WHWK Current | Award | Sep 15, 2026 | $0 |
| Whitehawk Therapeutics, Inc. WHWK | Award | Sep 15, 2026 | $0 |